Lexicon Pharma (LXRX) reported Q1 Revenue
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.25 -5.46%
EPS Growth %: -600.0%
Financial Fact:
Total operating expenses: 62.65M
Today's EPS Names:
HYFT, ESBS, PFBK, More
EPS Growth %: -600.0%
Financial Fact:
Total operating expenses: 62.65M
Today's EPS Names:
HYFT, ESBS, PFBK, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 Revenue for the quarter came in at $21.1 million versus the consensus estimate of $9.78 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
- First Bancorp (FNLC) Tops Q2 EPS by 85c
- First Industrial Realty (FR) Tops Q2 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
